✦ LIBER ✦
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95
✍ Scribed by Audrey Simon; Michel Peoch; Philippe Casassus; Eric Deconinck; Philippe Colombat; Bernard Desablens; Olivier Tournilhac; Houchingue Eghbali; Charles Foussard; Jerome Jaubert; Jean Pierre Vilque; Jean François Rossi; Virginie Lucas; Vincent Delwail; Antoine Thyss; Frederic Maloisel; Noel Milpied; Steven Le Gouill; Thierry Lamy; Rémy Gressin
- Book ID
- 108676918
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 237 KB
- Volume
- 151
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.